Project description
Decoding human genetic variation
Genome-wide association studies have played a crucial role in identifying genetic variants associated with various diseases. Interestingly, these studies have shown that a substantial proportion of disease-associated loci are located in intergenic regions initially believed to be non-functional. However, determining the impact of single allele variants on gene expression is difficult due to limited information on combinations of genetic variants that are inherited together on the same chromosome. Funded by the European Research Council, the HAP-PHEN project aims to identify genetic variants that affect gene expression in breast and other types of cancer. The overall goal is to improve cancer risk assessment and provide better insight into complex gene-regulation mechanisms.
Objective
High-throughput sequencing methods are breaching the barrier of $1000 per genome. This means that it will become feasible to sequence the genomes of many individual and create a deep catalog of the bulk of human genetic variation. A great task will lie in assigning function to all this genetic variation. Genome wide association studies have already shown that 40% of all loci significantly associated with disease are found in intergenic, supposedly regulatory regions. One of the current challenges in human genetics is that variants that affect expression on a single allele cannot be directly linked, because only have genotype information, rather then haplotype information. The overarching aim of the project is to resolve haplotypes in order to identify genetic variants that affect gene expression. We will do this in three sub-projects. In the first main project we will use 3D genome information gathered from Hi-C experiments to haplotype the genomes of six lymphoblastoid cell lines. We will integrate these data with chromatin profiling and RNAseq data in order to build integrative models for the prediction of gene expression and the effect of genetic variation on gene expression. In the second project we will perform haplotyping the breast cancer genes BRCA1/2 in a large cohort of individuals that come from families with a high-risk of hereditary breast cancer. Allelic imbalance in BRCA1/2 expression levels are known to be associated with an increased risk for breast cancer. We will aim to find genetic variants that are associated with a decreased allelic expression of BRCA1/2 to improve breast cancer risk assessment. Finally, we will develop a novel tool to study 3D genome organization of single alleles, which will allow us to identify how individual alleles are organized in the nucleus and identify multi-way interactions (i.e. involving more than two genomic loci). With this we hope to better understand how complex 3D organization contributes to gene regulation.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
- medical and health sciencesclinical medicineoncologybreast cancer
- medical and health sciencesclinical medicinecardiologycardiovascular diseases
- natural sciencesbiological sciencesgeneticsnucleotides
- medical and health sciencesbasic medicinemedical genetics
- natural sciencesbiological sciencesgeneticsgenomes
You need to log in or register to use this function
Programme(s)
Topic(s)
Funding Scheme
ERC-STG - Starting GrantHost institution
1066 CX Amsterdam
Netherlands